Medtronic | Sustainability Performance
Medtronic plc develops a wide array of medical devices and therapies. The company aims to improve patient outcomes through innovative healthcare solutions.
1949
Ireland
10,001+ employees
Medical Device
$10B+ in revenue
$1B - 10B in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#3253
Overallⓘ#24
in Irelandⓘ#47
in Medical DeviceⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsCarbon certificatesEnergy consumptionWaste ManagementWater ManagementNature and biodiversitySocial
Diversity and InclusionPay GapsHealth and SafetyExternalitiesGovernance
TargetsSDG ImpactFinancial Data
Business performanceCapital & innovationAnalyst projections
Aligned
Aligned
Leading
Aligned
Laggard
Intensity
Greenhouse gas intensity Scope 1, 2 (tCO₂e /$M)
Greenhouse gas intensity (Scope 1, 2, 3)(tCO₂e /$M)
Energy consumption (direct) intensity (MWh /$M)
Waste generation intensity (tonnes /$M)
Industry Benchmark
10.0
B/M 12.3
154.8
B/M 150.3
24.5
B/M 37.6
0.8
B/M 0.8
Powered by illuminem and GIST Impact
Controversy level
- Medtronic's Infuse bone graft product was linked to serious adverse events including cancer risk, leading to FDA warnings and significant litigation.
